novo nordisk cuts prices for its glp-1 drugs. Just Took a Big Swing, Slashing Drug Prices. Will It Pay Off the Healthcare Giant? Novo Nordisk to slash list

As patients seek more accessible, less invasive treatments for weight management, the oral segment is expected to expand, offering an alternative to injectable therapies while maintaining strong clinical efficacy

In contrast, a Scandinavian cohort study using nationwide cancer registries found no association between GLP-1RA use and thyroid cancer (HR 0.93, 95 % CI 0.661.31) (80)

judge has denied an injunction that prompted the FDA to update their guidance.

Prokinetic medications play a vital role in treating GLP-1 gastroparesis

Cognitive function in patients with diabetes mellitus: Guidance for daily care

August 6, 2025